(Q24246168)

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

Prophylaxis of Oral Candidiasis With Clotrimazole Troches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Practical modalities for prevention of fungal infections in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prophylaxis of oropharyngeal candidiasis with fluconazole.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

[Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prophylactic use of fluconazole in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prophylaxis of oropharyngeal candidiasis with clotrimazole.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB2

7 January 2021

10.1002/14651858.CD003807.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3810694

OpenCitations bibliographic resource ID

3810694

1 reference